BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1951 related articles for article (PubMed ID: 23973922)

  • 1. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
    Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
    Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
    J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
    Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
    Front Immunol; 2018; 9():1078. PubMed ID: 29892282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.
    Sala E; Genua M; Petti L; Anselmo A; Arena V; Cibella J; Zanotti L; D'Alessio S; Scaldaferri F; Luca G; Arato I; Calafiore R; Sgambato A; Rutella S; Locati M; Danese S; Vetrano S
    Gastroenterology; 2015 Jul; 149(1):163-176.e20. PubMed ID: 25790743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human umbilical cord blood mesenchymal stem cell-derived PGE2 and TGF-β1 alleviate atopic dermatitis by reducing mast cell degranulation.
    Kim HS; Yun JW; Shin TH; Lee SH; Lee BC; Yu KR; Seo Y; Lee S; Kang TW; Choi SW; Seo KW; Kang KS
    Stem Cells; 2015 Apr; 33(4):1254-66. PubMed ID: 25522163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells-regulated Treg cells suppress colitis-associated colorectal cancer.
    Tang RJ; Shen SN; Zhao XY; Nie YZ; Xu YJ; Ren J; Lv MM; Hou YY; Wang TT
    Stem Cell Res Ther; 2015 Apr; 6(1):71. PubMed ID: 25889203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord-derived mesenchymal stem cells downregulate inflammatory responses by shifting the Treg/Th17 profile in experimental colitis.
    Li L; Liu S; Xu Y; Zhang A; Jiang J; Tan W; Xing J; Feng G; Liu H; Huo F; Tang Q; Gu Z
    Pharmacology; 2013; 92(5-6):257-64. PubMed ID: 24280970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis.
    Liang L; Dong C; Chen X; Fang Z; Xu J; Liu M; Zhang X; Gu DS; Wang D; Du W; Zhu D; Han ZC
    Cell Transplant; 2011; 20(9):1395-408. PubMed ID: 21396175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis.
    Nam YS; Kim N; Im KI; Lim JY; Lee ES; Cho SG
    World J Gastroenterol; 2015 Feb; 21(7):2030-9. PubMed ID: 25717235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats.
    Tanaka F; Tominaga K; Ochi M; Tanigawa T; Watanabe T; Fujiwara Y; Ohta K; Oshitani N; Higuchi K; Arakawa T
    Life Sci; 2008 Dec; 83(23-24):771-9. PubMed ID: 18950645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of DSS-induced colitis in mice by TNF-α-stimulated mesenchymal stem cells derived from feline adipose tissue via COX-2/PGE
    Kim K; An JH; Park SM; Lim G; Seo KW; Youn HY
    J Vet Sci; 2023 Jul; 24(4):e52. PubMed ID: 37532297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide.
    Macho Fernandez E; Valenti V; Rockel C; Hermann C; Pot B; Boneca IG; Grangette C
    Gut; 2011 Aug; 60(8):1050-9. PubMed ID: 21471573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonic expression of the peptide transporter PEPT1 is downregulated during intestinal inflammation and is not required for NOD2-dependent immune activation.
    Wuensch T; Ullrich S; Schulz S; Chamaillard M; Schaltenberg N; Rath E; Goebel U; Sartor RB; Prager M; Büning C; Bugert P; Witt H; Haller D; Daniel H
    Inflamm Bowel Dis; 2014 Apr; 20(4):671-84. PubMed ID: 24583477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of NOD1 and NOD2 for the differentiation of multipotent mesenchymal stem cells derived from human umbilical cord blood.
    Kim HS; Shin TH; Yang SR; Seo MS; Kim DJ; Kang SK; Park JH; Kang KS
    PLoS One; 2010 Oct; 5(10):e15369. PubMed ID: 21042538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis.
    Shin TH; Kim HS; Kang TW; Lee BC; Lee HY; Kim YJ; Shin JH; Seo Y; Won Choi S; Lee S; Shin K; Seo KW; Kang KS
    Cell Death Dis; 2016 Dec; 7(12):e2524. PubMed ID: 28005072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paeoniflorin ameliorates experimental colitis by inhibiting gram-positive bacteria-dependent MDP-NOD2 pathway.
    Luo X; Wang X; Huang S; Xu B; Luo S; Li Y; Wang Q; Chen Y; Deng X; Liu L; Zhou L
    Int Immunopharmacol; 2021 Jan; 90():107224. PubMed ID: 33302036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo.
    Lee M; Jeong SY; Ha J; Kim M; Jin HJ; Kwon SJ; Chang JW; Choi SJ; Oh W; Yang YS; Kim JS; Jeon HB
    Biochem Biophys Res Commun; 2014 Apr; 446(4):983-9. PubMed ID: 24657442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell transplantation improves chronic colitis-associated complications through inhibiting the activity of toll-like receptor-4 in mice.
    Niu GC; Liu L; Zheng L; Zhang H; Shih DQ; Zhang X
    BMC Gastroenterol; 2018 Aug; 18(1):127. PubMed ID: 30103680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction.
    Yang Z; Fuss IJ; Watanabe T; Asano N; Davey MP; Rosenbaum JT; Strober W; Kitani A
    Gastroenterology; 2007 Nov; 133(5):1510-21. PubMed ID: 17915219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural differentiation of brain-derived neurotrophic factor-expressing human umbilical cord blood-derived mesenchymal stem cells in culture via TrkB-mediated ERK and β-catenin phosphorylation and following transplantation into the developing brain.
    Lim JY; Park SI; Kim SM; Jun JA; Oh JH; Ryu CH; Jeong CH; Park SH; Park SA; Oh W; Chang JW; Jeun SS
    Cell Transplant; 2011; 20(11-12):1855-66. PubMed ID: 21375801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.